-
UK PM 'open' to slavery apology but not reparations
-
West Indies crush Bangladesh by eight wickets in first Test
-
Kimono-clad pets blessed at Japan festival lacking enough kids
-
France on alert as Halloween protests raise risk of violence
-
Hakimi bags hat-trick as PSG rip Le Havre to pieces
-
Abhishek Sharma: Indian cricket's 'new-generation superstar'
-
In-form Fernandez sets up Tokyo final against Russia's Shnaider
-
Marquez stretches MotoGP championship lead after Martin pulls out
-
Scam centres relocated from Cambodia operate in Madagascar
-
In-form Fernandez reaches Tokyo final
-
Marc Marquez on front row at Malaysian MotoGP as Martin ruled out
-
James, Maxey fuel 76ers over Knicks in NBA Cup thriller
-
Injured Martin out of Malaysian MotoGP in big title blow
-
High-speed, high-risk Route du Rhum yacht race sets off Sunday
-
US, S.Korea, Japan vow 'complete' N.Korea denuclearization
-
Fears of violence as France braces for Halloween protests
-
Nations commit to get nature goals back on track
-
OKC's Holmgren to miss at least eight weeks as Thunder injury woes deepen
-
US oil companies aim to squeeze more out of refineries
-
'Not very smart' - Verstappen slams Red Bull stable-mate after clash
-
Leclerc quickest in Mexico GP practice
-
Trump admin approves potential Patriot missiles sale to Ukraine
-
Polish riot police deployed as deposed court chief sets off crisis
-
Sun Goddess wins at Breeders' Cup, O'Brien leads Baffert
-
Young Canadians focus on mental health at key climate trial
-
Nations agree push to get nature goals on track
-
'Breath of fresh air' truce brings hope to Ukraine's ravaged Kherson
-
Leclerc shows practice pace as Antonelli prowls in Mexico
-
British king reflects on colonial atrocities in Guyana
-
Trump, Milei under pressure to explain Bolsonaro flight from Brazil
-
Nations agree crucial texts in overtime at UN nature summit
-
Hakimi bags hat-trick as Paris Saint-Germain rip Le Havre to pieces
-
NBA Trail Blazers lose guard Morant for four weeks
-
Polish riot police deployed after court chief suspended
-
UN nature summit in extra time as nations grapple for deal
-
Emery's focus fully on Fulham despite Barcelona tie
-
Complaints upheld against Swiss TV commentary on Israeli bobsleigher
-
Reigning champs chase history in New York Marathon
-
Tielemans glad Man Utd sticking with Carrick
-
Monaco taken off global money-laundering 'grey list'
-
Scottish police probe Andrew, Epstein stay at royal castle: UK media
-
Canada, EU launch new alliance with deals on Ukraine, minerals, AI
-
Medvedev into Vienna semis and books ATP Finals place
-
Tears, fear, anger: relatives of Spain train crash dead await fate
-
UN nature talks in extra time as nations struggle to reach deal
-
Spurs get Maddison boost ahead of Palace clash
-
Meta settles, leaving Snap sole defendant in new social media trial
-
French authorities fear new street violence at Halloween protests
-
Chelsea manager Alonso dismisses talk of Estevao loan deal
-
Rickelton, Mulder centuries lift South Africa's chances in Test decider
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
H.Kuenzler--VB